Literature DB >> 343719

Plane xanthoma and multiple myeloma with lipoprotein--paraprotein complexing.

J S Taylor, L A Lewis, J D Battle, A Butkus, A L Robertson, S Deodhar, H H Roenigk.   

Abstract

Clinicopathologic findings are reported of a woman with generalized plane xanthoma, multiple myeloma (IgG type K), and hyperlipemia with very high levels of serum cholesterol and triglyceride. Complexing of the serum lipoproteins and immunoglobulins had cryoglobulin properties and was separable by ultracentrifugation. Immunofluorescent studies of skin and bone marrow demonstrated deposits of IgG with low density lipoprotein apoprotein and IgG with beta-lipoprotein, respectively. Although immunosuppressive therapy resulted in return of serum IgG, lipid, and lipoprotein levels to normal, the patient died from the myeloma. Serum lipoprotein-paraprotein complexes have been demonstrated in at least 20 other cases of cutaneous xanthomatosis and myeloma. This interaction may result in an autoimmune hyperlipemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343719

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  5 in total

1.  Diffuse Normolipemic Plane Xanthomatosis with Immunoglobulin-Lambda Light-Chain Deposition in a Patient with Multiple Myeloma.

Authors:  Sul Hee Lee; Ji Yeoun Shin; Sang-Hoon Lee; Young Lip Park
Journal:  Ann Dermatol       Date:  2019-02-28       Impact factor: 1.444

2.  Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus.

Authors:  J L Witztum; U P Steinbrecher; Y A Kesaniemi; M Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

3.  Immune complex hyperlipidemia induced by an apolipoprotein-reactive immunoglobulin A paraprotein from a patient with multiple myeloma. Characterization of this immunoglobulin.

Authors:  L L Kilgore; B W Patterson; D M Parenti; W R Fisher
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

4.  Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia.

Authors:  K R Feingold; G R Castro; Y Ishikawa; P E Fielding; C J Fielding
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

5.  Atypical type III hyperlipoproteinemia in a patient with Ig A myelomatosis.

Authors:  G Feussner; E von Hodenberg; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-05-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.